BMRN
Price
$88.61
Change
+$0.87 (+0.99%)
Updated
Mar 27, 6:59 PM EST
27 days until earnings call
MESO
Price
$3.49
Change
-$0.44 (-11.20%)
Updated
Mar 27, 6:59 PM EST
63 days until earnings call
Ad is loading...

Compare trend and price BMRN vs MESO

Header iconBMRN vs MESO Comparison
Open Charts BMRN vs MESOBanner chart's image
BioMarin Pharmaceutical
Price$88.61
Change+$0.87 (+0.99%)
Volume$551.14K
CapitalizationN/A
Mesoblast
Price$3.49
Change-$0.44 (-11.20%)
Volume$2.71M
CapitalizationN/A
View a ticker or compare two or three
BMRN vs MESO Comparison Chart

Loading...

BMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BMRN vs. MESO commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and MESO is a Buy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (BMRN: $88.63 vs. MESO: $3.48)
Brand notoriety: BMRN and MESO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 64% vs. MESO: 245%
Market capitalization -- BMRN: $16.72B vs. MESO: $328.42M
BMRN [@Biotechnology] is valued at $16.72B. MESO’s [@Biotechnology] market capitalization is $328.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileMESO’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • MESO’s FA Score: 0 green, 5 red.
According to our system of comparison, MESO is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish.

  • BMRN’s TA Score: 5 bullish, 5 bearish.

Price Growth

BMRN (@Biotechnology) experienced а +4.57% price change this week, while MESO (@Biotechnology) price change was +50.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

BMRN is expected to report earnings on Apr 24, 2024.

MESO is expected to report earnings on May 30, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BMRN with price predictions.
OPEN
A.I.dvisor published
a Summary for MESO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BMRN($16.7B) has a higher market cap than MESO($328M). BMRN has higher P/E ratio than MESO: BMRN (101.87) vs MESO (0.12). MESO YTD gains are higher at: 58.182 vs. BMRN (-8.079). BMRN has higher annual earnings (EBITDA): 310M vs. MESO (-48.7M). BMRN has more cash in the bank: 1.07B vs. MESO (77.1M). MESO has less debt than BMRN: MESO (122M) vs BMRN (1.1B). BMRN has higher revenues than MESO: BMRN (2.42B) vs MESO (7.47M).
BMRNMESOBMRN / MESO
Capitalization16.7B328M5,091%
EBITDA310M-48.7M-637%
Gain YTD-8.07958.182-14%
P/E Ratio101.870.1283,679%
Revenue2.42B7.47M32,396%
Total Cash1.07B77.1M1,393%
Total Debt1.1B122M898%
FUNDAMENTALS RATINGS
BMRN vs MESO: Fundamental Ratings
BMRN
MESO
OUTLOOK RATING
1..100
992
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8695
PRICE GROWTH RATING
1..100
6036
P/E GROWTH RATING
1..100
7894
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (83) in the Biotechnology industry is in the same range as MESO (88). This means that BMRN’s stock grew similarly to MESO’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MESO (100). This means that BMRN’s stock grew similarly to MESO’s over the last 12 months.

BMRN's SMR Rating (86) in the Biotechnology industry is in the same range as MESO (95). This means that BMRN’s stock grew similarly to MESO’s over the last 12 months.

MESO's Price Growth Rating (36) in the Biotechnology industry is in the same range as BMRN (60). This means that MESO’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (78) in the Biotechnology industry is in the same range as MESO (94). This means that BMRN’s stock grew similarly to MESO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRN
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Declines
ODDS (%)
Bearish Trend 7 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Ad is loading...
BMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGRX0.370.04
+10.78%
Agile Therapeutics
SN62.942.05
+3.37%
SharkNinja
SLNA0.230.01
+3.10%
Selina Hospitality PLC
RKLB4.140.08
+1.85%
Rocket Lab USA
CNSL4.330.03
+0.70%
Consolidated Communications Holdings

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with SRPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.01%
SRPT - BMRN
45%
Loosely correlated
+1.53%
FOLD - BMRN
45%
Loosely correlated
+3.85%
AXON - BMRN
42%
Loosely correlated
-1.13%
FGEN - BMRN
41%
Loosely correlated
+5.53%
NTLA - BMRN
40%
Loosely correlated
+2.82%
More

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been closely correlated with SAGE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MESO jumps, then SAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
-11.45%
SAGE - MESO
66%
Closely correlated
+2.42%
QTTB - MESO
46%
Loosely correlated
-2.88%
TNGX - MESO
33%
Poorly correlated
+2.66%
TSVT - MESO
32%
Poorly correlated
+8.47%
ADCT - MESO
29%
Poorly correlated
-3.45%
More